Elevated endothelin-1 (ET-1) levels may contribute to hypoadiponectinemia in childhood obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages

  Nacci, Carmela ^a   Leo, Valentina ^a   De Benedictis, Leonarda ^a   Carratù, Maria Rosaria ^a   Bartolomeo, Nicola ^a   Altomare, Maria ^a   Giordano, Paola ^a   Faienza, Maria Felicia ^a   Montagnani, Monica ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADIPONECTIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; MESSENGER RNA; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADIPOCYTE; ANIMAL TISSUE; ARTICLE; CHILD; CHILDHOOD OBESITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOADIPONECTINEMIA; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NONHUMAN; OBESITY; PATHOGENESIS; PEDIATRICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SCHOOL CHILD; VASCULARIZATION; VASODILATATION;

3T3-L1 CELLS; ADIPONECTIN; AGE OF ONSET; ANIMALS; CHILD; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; METABOLISM, INBORN ERRORS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OBESITY; OVERWEIGHT; RATS; RATS, WISTAR; THINNESS;

RATTUS;

EID: 84876204634     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4119     Document Type: Article

References (52)

1. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1:11-25.
2. van Vliet M, Heymans MW, von Rosenstiel IA, Brandjes DP, Beijnen JH, Diamant M. Cardiometabolic risk variables in overweight and obese children: a worldwide comparison. Cardiovasc Diabetol. 2011;10:106.
3. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010;362:485-493.
4. Juonala M, Magnussen CG, Berenson GS, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365:1876-1885.
5. Montero D, Walther G, Perez-Martin A, Roche E, Vinet A. Endothelial dysfunction, inflammation, and oxidative stress inobese children and adolescents: markers and effect of lifestyle intervention. Obes Rev. 2012;13:441-455.
6. Eringa EC, Bakker W, Smulders YM, Serne EH, Yudkin JS, Stehouwer CD. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation. 2007;14:389-402.
7. Zhou J, Qin G. Adipocyte dysfunction and hypertension. Am J Cardiovasc Dis. 2012;2:143-149.
8. Saint-Marc P, Kozak LP, Ailhaud G, Darimont C, Negrel R. Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology. 2001;142:487-492.
9. Mohite A, Chillar A, So SP, Cervantes V, Ruan KH. Novel mechanism of the vascular protector prostacyclin: regulating microRNA expression. Biochemistry. 2011;50:1691-1699.
10. Sansbury BE, Cummins TD, Tang Y, et al. Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype. Circ Res. 2012;111:1176-1189.
11. Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: the yin and yang on vascular function. Curr Med Chem. 2006;13:1655-1665.
12. Cardillo C, Campia U, Bryant MB, Panza JA. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation. 2002;106:1783-1787.
13. Barath A, Turi S, Nemeth I, et al. Different pathomechanisms of essential and obesity-associated hypertension in adolescents. Pediatr Nephrol. 2006;21:1419-1425.
14. Wilkes JJ, Hevener A, Olefsky J. Chronic endothelin-1 treatment leads to insulin resistance in vivo. Diabetes. 2003;52:1904-1909.
15. Ishibashi KI, Imamura T, Sharma PM, Huang J, Ugi S, Olefsky JM. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. J Clin Invest. 2001; 107:1193-1202.
16. Hauner H, Petruschke T, Gries FA. Endothelin-1 inhibits the adipose differentiation of cultured human adipocyte precursor cells. Metabolism. 1994;43:227-232.
17. Ishida F, Saeki K, Saeki T, et al. Suppressive effects of the endothelin receptor (ETA) antagonist BQ-123 on ET-1-induced reduction of lipoprotein lipase activity in 3T3-L1 adipocytes. Biochem Pharmacol. 1992;44:1431-1436.
18. Usui I, Imamura T, Babendure JL, et al. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Gαq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol Endocrinol. 2005;19:2760-2768.
19. Juan CC, Chang CL, Lai YH, Ho LT. Endothelin-1 induces lipolysis in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab. 2005;288: E1146-E1152.
20. Clarke KJ, Zhong Q, Schwartz DD, Coleman ES, Kemppainen RJ, Judd RL. Regulation of adiponectin secretion by endothelin-1. Biochem Biophys Res Commun. 2003;312:945-949.
21. Bedi D, Clarke KJ, Dennis JC, et al. Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/actin-dependent mechanism. Biochem Biophys Res Commun. 2006; 345:332-339.
22. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003;278:45021-45026.
23. Hattori Y, Suzuki M, Hattori S, Kasai K. Globular adiponectin up-regulates nitric oxide production in vascular endothelial cells. Diabetologia. 2003;46:1543-1549.
24. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med. 2005;11:1096-1103.
25. Addabbo F, Nacci C, De Benedictis L, Leo V, Tarquinio M, Quon MJ, Montagnani M. Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-κB/COX-2 signaling in human aortic endothelial cells. Am J Physiol Endocrinol Metab. 2011;301:E1143-E1154.
26. Ouchi N, Ohishi M, Kihara S, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003;42: 231-234.
27. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002;277:25863-25866.
28. Fujioka D, Kawabata K, Saito Y, et al. Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol. 2006;290:H2409-H2416.
29. Bussey CT, Kolka CM, Rattigan S, Richards SM. Adiponectin opposes endothelin-1-mediated vasoconstriction in the perfused rat hindlimb. Am J Physiol Heart Circ Physiol. 2011;301:H79-H86.
30. Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23:85-89.
31. Iwashima Y, Katsuya T, Ishikawa K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004; 43:1318-1323.
32. Han SH, Sakuma I, Shin EK, Koh KK. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis. 2009;52:126-140.
33. Riestra P, Garcia-Anguita A, Lasuncion MA, Cano B, de Oya M, Garces C. Relationship of adiponectin with metabolic syndrome components in pubertal children. Atherosclerosis. 2011;216:467-470.
34. Giordano P, Del Vecchio GC, Cecinati V, et al. Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediatr. 2011;170:845-850.
35. Kamon J, Yamauchi T, Muto S, et al. A novel IKKβ inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance. Biochem Biophys Res Commun. 2004;323:242-248.
36. Engeli S, Feldpausch M, Gorzelniak K, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes. 2003;52:942-947.
37. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240-1243.
38. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. 2000 CDC growth charts: United States. Adv Data:1-27.
39. Williams CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2002;106:143-160.
40. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-2410.
41. Potenza MA, Gagliardi S, De Benedictis L, et al. Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature. Am J Physiol Endocrinol Metab. 2009;297:E685-E694.
42. Wang Y, Lam KS, Yau MH, Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J. 2008;409:623-633.
43. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113: 1888-1904.
44. Shindo T, Kurihara H, Maemura K, et al. Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1. J Mol Med (Berl). 2002;80:105-116.
45. Amiri F, Virdis A, Neves MF, et al. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation. 2004;110:2233-2240.
46. Amiri F, Paradis P, Reudelhuber TL, Schiffrin EL. Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 inendothelial cells. J Hypertens. 2008;26:1102-1109.
47. Leung JW, Wong WT, Koon HW, et al. Transgenic mice over-expressing ET-1 in the endothelial cells develop systemic hypertension with altered vascular reactivity. PLoS One. 2011;6:e26994.
48. Iwasa N, Emoto N, Widyantoro B, Miyagawa K, Nakayama K, Hirata K. Knockout of endothelin-1 in vascular endothelial cells protects against insulin resistance induced by high-salt diet in mice. Kobe J Med Sci. 2010;56:E85-E91.
49. Xiong Y, Tanaka H, Richardson JA, et al. Endothelin-1 stimulates leptin production in adipocytes. J Biol Chem. 2001;276:28471-28477.
50. Chai SP, Juan CC, Kao PH, Wang DH, Fong JC. Synergistic induction of interleukin-6 expression by endothelin-1 and cyclic AMP in adipocytes. Int J Obes (Lond). 2013;37(2):197-203.
51. Chai SP, Chang YN, Fong JC. Endothelin-1 stimulates interleukin-6 secretion from 3T3-L1 adipocytes. Biochim Biophys Acta. 2009; 1790:213-218.
52. Chang HH, Huang YM, Wu CP, et al. Endothelin-1 stimulates suppressor of cytokine signaling-3 gene expression in adipocytes. Gen Comp Endocrinol. 2012;178:450-458.